ArticlePloS one2015

Application of allogeneic bone marrow cells in view of residual alloreactivity: sirolimus but not cyclosporine evolves tolerogenic properties.

Kai Timrott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.